Related Experiment Video
Updated: Mar 19, 2026

06:35
A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants
Published on: October 10, 2022
2.5K
The E3 Ubiquitin Ligase UBE3B Regulates Synaptic Development and Cortical Network Activity
Shayal Vashisth1, Aleya Shedd1, Ariel Aiken2
1Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Summary
Loss of UBE3B causes severe neurodevelopmental deficits in mice, impacting social behavior, learning, and motor skills. This highlights UBE3B
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Autism spectrum disorder (ASD) is a neurodevelopmental disorder linked to impaired communication and social interaction.
- Pathogenic mutations in UBE3B cause neurodevelopmental diseases, including ASD.
- The ubiquitin-proteasome system (UPS) is crucial for neurodevelopment, with UPS gene mutations implicated in ASD.
Purpose of the Study:
- To investigate the brain function of UBE3B and its role in neurodevelopmental abnormalities.
- To generate and evaluate a central nervous system-specific conditional Ube3b knockout (cKO) mouse model.
Main Methods:
- Generated a central nervous system-specific conditional Ube3b knockout (cKO) mouse model.
- Evaluated neurobehavioral phenotypes, including vocalization, social behavior, learning, memory, and motor skills.
- Assessed in vivo neuronal phenotypes, proteome, and ubiquitome of neural stem cells.
Main Results:
- Ube3b cKO mice displayed severe deficits in vocalization, social behavior, learning, memory, and motor skills.
- Neuronal analyses revealed defects in dendritic morphogenesis, reduced excitatory synapse density, and altered cortical circuit activity.
- Proteomic analysis identified 116 proteins with altered levels and ubiquitination in Ube3b-deficient neural stem cells, enriched for synaptic functions.
Conclusions:
- UBE3B plays a critical role in regulating social, cognitive, and motor functions.
- UBE3B is essential for neuronal morphogenesis and activity by modulating the synaptic proteome.
- Disruption of UBE3B function contributes to neurodevelopmental abnormalities relevant to ASD.
Related Concept Videos
Regulated Protein Degradation
9.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.2K
Covalently Linked Protein Regulators
9.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
9.9K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Drugs Affecting Neurotransmitter Release or Uptake
1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
The Proteasome
1.9K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.9K
The Proteasome
10.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.4K

